Skip to main content

Dr Tward Discusses 2022 Anticipated Prostate Cancer Advancements Part 2


In part two of this series, Dr Tward, MD, Huntsman Cancer Institute, discusses use of the Polaris test to prognosticate metastasis of men undergoing radiation therapy with prostate cancer, as well as ongoing efforts to further advance personalized treatment in the prostate cancer space.